Self-Reported Sexual Function Measures Administered to Female Cancer Patients

A Systematic Review, 2008-2014

Diana D. Jeffery, Lisa Barbera, Barbara L. Andersen, Amy K. Siston, Anuja Jhingran, Shirley R. Baron, Jennifer Barsky Reese, Deborah J. Coady, Jeanne Carter, Kathryn E. Flynn

Research output: Contribution to journalArticle

Abstract

A systematic review was conducted to identify and characterize self-reported sexual function (SF) measures administered to women with a history of cancer. Using 2009 PRISMA guidelines, we searched electronic bibliographic databases for quantitative studies published January 2008-September 2014 that used a self-reported measure of SF, or a quality of life (QOL) measure that contained at least 1 item pertaining to SF. Of 1,487 articles initially identified, 171 were retained. The studies originated in 36 different countries with 23% from US-based authors. Most studies focused on women treated for breast, gynecologic, or colorectal cancer. About 70% of the articles examined SF as the primary focus; the remaining examined QOL, menopausal symptoms, or compared treatment modalities. We identified 37 measures that assessed at least one domain of SF, eight of which were dedicated SF measures developed with cancer patients. Almost one third of the studies used EORTC QLQ modules to assess SF, and another third used the Female Sexual Function Inventory. There were few commonalities among studies, though nearly all demonstrated worse SF after cancer treatment or compared to healthy controls. QOL measures are better suited to screening while dedicated SF questionnaires provide data for more in depth assessment. This systematic review will assist oncology clinicians and researchers in their selection of measures of SF and encourage integration of this quality of life domain in patient care.

Original languageEnglish (US)
Pages (from-to)433-466
Number of pages34
JournalJournal of Psychosocial Oncology
Volume33
Issue number4
DOIs
StatePublished - Jul 4 2015
Externally publishedYes

Fingerprint

Quality of Life
Neoplasms
Bibliographic Databases
Colorectal Neoplasms
Patient Care
Research Personnel
Guidelines
Breast Neoplasms
Equipment and Supplies
Therapeutics

Keywords

  • cancer
  • females
  • psychosocial
  • quality of life
  • sexual function

ASJC Scopus subject areas

  • Applied Psychology
  • Oncology
  • Psychiatry and Mental health
  • Medicine(all)

Cite this

Jeffery, D. D., Barbera, L., Andersen, B. L., Siston, A. K., Jhingran, A., Baron, S. R., ... Flynn, K. E. (2015). Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014. Journal of Psychosocial Oncology, 33(4), 433-466. https://doi.org/10.1080/07347332.2015.1046012

Self-Reported Sexual Function Measures Administered to Female Cancer Patients : A Systematic Review, 2008-2014. / Jeffery, Diana D.; Barbera, Lisa; Andersen, Barbara L.; Siston, Amy K.; Jhingran, Anuja; Baron, Shirley R.; Reese, Jennifer Barsky; Coady, Deborah J.; Carter, Jeanne; Flynn, Kathryn E.

In: Journal of Psychosocial Oncology, Vol. 33, No. 4, 04.07.2015, p. 433-466.

Research output: Contribution to journalArticle

Jeffery, DD, Barbera, L, Andersen, BL, Siston, AK, Jhingran, A, Baron, SR, Reese, JB, Coady, DJ, Carter, J & Flynn, KE 2015, 'Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014', Journal of Psychosocial Oncology, vol. 33, no. 4, pp. 433-466. https://doi.org/10.1080/07347332.2015.1046012
Jeffery, Diana D. ; Barbera, Lisa ; Andersen, Barbara L. ; Siston, Amy K. ; Jhingran, Anuja ; Baron, Shirley R. ; Reese, Jennifer Barsky ; Coady, Deborah J. ; Carter, Jeanne ; Flynn, Kathryn E. / Self-Reported Sexual Function Measures Administered to Female Cancer Patients : A Systematic Review, 2008-2014. In: Journal of Psychosocial Oncology. 2015 ; Vol. 33, No. 4. pp. 433-466.
@article{5651254fc1864a7f9c44ce01299858a0,
title = "Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014",
abstract = "A systematic review was conducted to identify and characterize self-reported sexual function (SF) measures administered to women with a history of cancer. Using 2009 PRISMA guidelines, we searched electronic bibliographic databases for quantitative studies published January 2008-September 2014 that used a self-reported measure of SF, or a quality of life (QOL) measure that contained at least 1 item pertaining to SF. Of 1,487 articles initially identified, 171 were retained. The studies originated in 36 different countries with 23{\%} from US-based authors. Most studies focused on women treated for breast, gynecologic, or colorectal cancer. About 70{\%} of the articles examined SF as the primary focus; the remaining examined QOL, menopausal symptoms, or compared treatment modalities. We identified 37 measures that assessed at least one domain of SF, eight of which were dedicated SF measures developed with cancer patients. Almost one third of the studies used EORTC QLQ modules to assess SF, and another third used the Female Sexual Function Inventory. There were few commonalities among studies, though nearly all demonstrated worse SF after cancer treatment or compared to healthy controls. QOL measures are better suited to screening while dedicated SF questionnaires provide data for more in depth assessment. This systematic review will assist oncology clinicians and researchers in their selection of measures of SF and encourage integration of this quality of life domain in patient care.",
keywords = "cancer, females, psychosocial, quality of life, sexual function",
author = "Jeffery, {Diana D.} and Lisa Barbera and Andersen, {Barbara L.} and Siston, {Amy K.} and Anuja Jhingran and Baron, {Shirley R.} and Reese, {Jennifer Barsky} and Coady, {Deborah J.} and Jeanne Carter and Flynn, {Kathryn E.}",
year = "2015",
month = "7",
day = "4",
doi = "10.1080/07347332.2015.1046012",
language = "English (US)",
volume = "33",
pages = "433--466",
journal = "Journal of Psychosocial Oncology",
issn = "0734-7332",
publisher = "Routledge",
number = "4",

}

TY - JOUR

T1 - Self-Reported Sexual Function Measures Administered to Female Cancer Patients

T2 - A Systematic Review, 2008-2014

AU - Jeffery, Diana D.

AU - Barbera, Lisa

AU - Andersen, Barbara L.

AU - Siston, Amy K.

AU - Jhingran, Anuja

AU - Baron, Shirley R.

AU - Reese, Jennifer Barsky

AU - Coady, Deborah J.

AU - Carter, Jeanne

AU - Flynn, Kathryn E.

PY - 2015/7/4

Y1 - 2015/7/4

N2 - A systematic review was conducted to identify and characterize self-reported sexual function (SF) measures administered to women with a history of cancer. Using 2009 PRISMA guidelines, we searched electronic bibliographic databases for quantitative studies published January 2008-September 2014 that used a self-reported measure of SF, or a quality of life (QOL) measure that contained at least 1 item pertaining to SF. Of 1,487 articles initially identified, 171 were retained. The studies originated in 36 different countries with 23% from US-based authors. Most studies focused on women treated for breast, gynecologic, or colorectal cancer. About 70% of the articles examined SF as the primary focus; the remaining examined QOL, menopausal symptoms, or compared treatment modalities. We identified 37 measures that assessed at least one domain of SF, eight of which were dedicated SF measures developed with cancer patients. Almost one third of the studies used EORTC QLQ modules to assess SF, and another third used the Female Sexual Function Inventory. There were few commonalities among studies, though nearly all demonstrated worse SF after cancer treatment or compared to healthy controls. QOL measures are better suited to screening while dedicated SF questionnaires provide data for more in depth assessment. This systematic review will assist oncology clinicians and researchers in their selection of measures of SF and encourage integration of this quality of life domain in patient care.

AB - A systematic review was conducted to identify and characterize self-reported sexual function (SF) measures administered to women with a history of cancer. Using 2009 PRISMA guidelines, we searched electronic bibliographic databases for quantitative studies published January 2008-September 2014 that used a self-reported measure of SF, or a quality of life (QOL) measure that contained at least 1 item pertaining to SF. Of 1,487 articles initially identified, 171 were retained. The studies originated in 36 different countries with 23% from US-based authors. Most studies focused on women treated for breast, gynecologic, or colorectal cancer. About 70% of the articles examined SF as the primary focus; the remaining examined QOL, menopausal symptoms, or compared treatment modalities. We identified 37 measures that assessed at least one domain of SF, eight of which were dedicated SF measures developed with cancer patients. Almost one third of the studies used EORTC QLQ modules to assess SF, and another third used the Female Sexual Function Inventory. There were few commonalities among studies, though nearly all demonstrated worse SF after cancer treatment or compared to healthy controls. QOL measures are better suited to screening while dedicated SF questionnaires provide data for more in depth assessment. This systematic review will assist oncology clinicians and researchers in their selection of measures of SF and encourage integration of this quality of life domain in patient care.

KW - cancer

KW - females

KW - psychosocial

KW - quality of life

KW - sexual function

UR - http://www.scopus.com/inward/record.url?scp=84938381957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938381957&partnerID=8YFLogxK

U2 - 10.1080/07347332.2015.1046012

DO - 10.1080/07347332.2015.1046012

M3 - Article

VL - 33

SP - 433

EP - 466

JO - Journal of Psychosocial Oncology

JF - Journal of Psychosocial Oncology

SN - 0734-7332

IS - 4

ER -